Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Deep docking, part 2: an amplified DDU platform for ultra-large virtual screening.

Chemical science·2026

Same author

Identification of a Cytokine Biomarker for Prognostic Modeling of Breast Cancer-Related Lymphedema.

Cancer research communications·2026

Same author

A scalable reinforcement learning approach for screening large peptide libraries for bioactive peptide discovery.

Nature communications·2025

Same author

Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same author

Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Cancer research·2025

Same author

GraphComm predicts cell cell communication using a graph based deep learning method in single cell RNA sequencing data.

Scientific reports·2025

Same journal

STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.

Briefings in bioinformatics·2026

Same journal

A knowledge-guided deep learning framework for quantitative nucleic acid testing.

Briefings in bioinformatics·2026

Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026

Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026

Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026

Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 24, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning

Hossein Sharifi-Noghabi^1,2,3, Soheil Jahangiri-Tazehkand^4,3,5, Petr Smirnov^4,3,5

¹School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada.

Briefings in Bioinformatics

|August 12, 2021

Summary

This summary is machine-generated.

This study introduces guidelines for training machine learning models to predict drug sensitivity using cancer cell line data. Applying these recommendations will improve the development of reliable preclinical biomarkers for precision oncology.

Keywords:

drug response prediction machine learning pharmacogenomics

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Oct 24, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Area of Science:

Oncology
Bioinformatics
Computational Biology

Background:

Precision oncology aims to personalize cancer treatment using tumor genomic profiles.
Pharmacogenomics data from cancer cell lines are vital for predicting drug sensitivity.
Machine learning models are increasingly used for drug sensitivity prediction using omics data.

Purpose of the Study:

To establish comprehensive guidelines for training and validating machine learning models for drug sensitivity prediction.
To analyze the generalization of gene expression-based drug sensitivity predictors.
To challenge current practices in training and validating these predictive models.

Main Methods:

Development of a set of guidelines for training gene expression-based predictors.
Extensive analysis of the generalization capabilities of drug sensitivity predictors.
Evaluation of training dataset choices and drug sensitivity measures.

Main Results:

The proposed guidelines address key aspects of model training and validation.
Analysis reveals critical factors influencing the generalization of drug sensitivity predictors.
Current community practices in model development are critically examined.

Conclusions:

Adherence to these guidelines will foster the development of more robust preclinical biomarkers.
Improved model training and validation are essential for advancing precision oncology.
This work provides a framework for reliable drug sensitivity prediction in cancer research.